Dr. Yajing Sun | Novel Protocols | Best Researcher Award

Dr. Yajing Sun, University of Oklahoma Health Sciences Center, United States

Dr. Yajing Sun is an accomplished pharmaceutical scientist based at the University of Oklahoma Health Sciences Center, where she earned her Doctor of Philosophy in December 2021. Her academic journey began at Stony Brook University, where she achieved a Master of Science in Chemistry in May 2015, following her Bachelor of Science in Marine Pharmaceutical Science at China Pharmaceutical University in June 2013. 🌐 With a diverse educational background, Dr. Sun brings a wealth of knowledge and expertise to the pharmaceutical field, showcasing a commitment to advancing scientific research and innovation. 🔬 As a dedicated researcher, her interests span novel protocols in pharmaceutical science, with a focus on intracellular protein translocation. Leveraging her expertise, she incorporates cutting-edge technologies like machine-learning image processing into her work. 🤖💡 Dr. Sun’s contributions extend to the critical realm of human cancer tumors, where her multifaceted approach actively contributes to innovative solutions and breakthroughs in cancer research. 🌟 Her commitment to pushing the boundaries of knowledge makes Dr. Yajing Sun a valuable and dynamic contributor to the evolving field of pharmaceutical science. 👩‍🔬🎉

🎓 Education :

Dr. Yajing Sun is a highly accomplished individual in the field of pharmaceutical science, earning her Doctor of Philosophy from the University of Oklahoma Health Science Center in December 2021. Her academic journey began at Stony Brook University, where she attained a Master of Science in Chemistry in May 2015. Prior to her studies in the United States, she completed her Bachelor of Science in Marine Pharmaceutical Science at China Pharmaceutical University in June 2013. 🌐 With a diverse educational background, Dr. Sun brings a wealth of knowledge and expertise to the pharmaceutical field, demonstrating her commitment to advancing scientific research and innovation. Congratulations to Dr. Yajing Sun on her impressive academic achievements! 🎉

🌐 Professional Profiles :

Google Scholar

Scopus

🧠Research Interests 🔬🌐 :

🔬 Dr. Yajing Sun is a dedicated researcher with a passion for advancing pharmaceutical science. Her primary research interests encompass novel protocols in pharmaceutical science, focusing on cutting-edge areas such as intracellular protein translocation. 🧬 Leveraging her expertise, she also delves into the intersection of technology and healthcare, incorporating machine-learning image processing techniques into her work. 🤖💡 Dr. Sun’s research extends to the critical realm of human cancer tumors, where she actively contributes to the quest for innovative solutions and breakthroughs in cancer research. 🌟 Her multifaceted approach and commitment to pushing the boundaries of knowledge make Dr. Yajing Sun a valuable contributor to the field of pharmaceutical science. 👩‍🔬🎓

Publications Top Notes  :

1.  Far-red light-activatable prodrug of paclitaxel for the combined effects of photodynamic therapy and site-specific paclitaxel chemotherapy

Journal: Journal of Medicinal Chemistry

Published Year: 2016, Cited By: 106

2.  Mitomycin C Induces Immunogenic Cell Death Biomarkers In Human Bladder Tumors

Journal: The FASEB Journal

Published Year: 2020

3.  Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Journal: Journal of Controlled Release

Published Year: 2024

 

 

 

 

Dr. Yajing Sun | Novel Protocols | Best Researcher Award

You May Also Like